Background The evidence base for the treatment of mild obstructive sleep apnoea is limited
and definitions of disease severity vary. The MERGE trial investigated the clinical …

Study objectives To determine the short-term and long-term impacts of continuous positive
airway pressure (CPAP) therapy on health-related quality of life (HRQL) in patients with …

There is randomized controlled evidence that patients with sleep apnea–hypopnea
syndrome (SAHS) treated with continuous positive airway pressure (CPAP) have improved …

Patients with untreated obstructive sleep apnea hypopnea (OSAH) are predisposed to
developing hypertension, and therapy with continuous positive airway pressure (CPAP) may …

The sleep medicine community has increasingly recognized the necessity that clinical care
be based on high-quality levels of evidence. Although research supports a favorable …

Background: The sleep apnea–hypopnea syndrome is defined by a pathologic number of
respiratory events during sleep (the apnea–hypopnea index, defined as the number of …

Background Although continuous positive airway pressure (CPAP) has become the first line
of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy …

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep
apnea (OSA). Although CPAP improves symptoms (eg, daytime sleepiness), there is a lack …

The aim of this trial was to evaluate the effectiveness of continuous positive airway pressure
(CPAP) in patients with mild sleep apnea–hypopnea syndrome (SAHS). One hundred forty …

Continuous positive airway pressure (CPAP) has become the treatment of choice for
obstructive sleep apnea syndrome. Successful therapy with CPAP depends greatly on …